Multi-country non-interventional study on the effectiveness and safety of Empagliflozin in adult patients with type 2 diabetes in Europe and Asia

21/01/2019
02/04/2024
EU PAS number:
EUPAS27606
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

1245-0195-protocol-v1-0-final

English (1.43 MB - PDF) View document
Updated protocol

1245-0195-protocol-v2-0-final

First published: 22/02/2024
English (1.12 MB - PDF) View document
Study results
Study results

1245.195 Synopsis

English (639.71 KB - PDF) View document
Study report
Other information